Press Release - Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million Savings expected to help secure 30 million additional doses, protecting up to 7 million mo ...
The European Union’s influence and contribution to global health is quietly receding in a broader decline in donations to the ...
Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment.
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
Battles between the Trump administration and academic institutions are putting important biomedical advances in limbo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback